loxoprofen has been researched along with Respiratory Tract Infections in 2 studies
loxoprofen: RN given refers to parent cpd without isomeric designation; structure in first source
loxoprofen : A monocarboxylic acid that is propionic acid in which one of the hydrogens at position 2 is substituted by a 4-[(2-oxocyclopentyl)methyl]phenyl group. A prodrug that is rapidly converted into its active trans-alcohol metabolite following oral administration.
Respiratory Tract Infections: Invasion of the host RESPIRATORY SYSTEM by microorganisms, usually leading to pathological processes or diseases.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To investigate whether loxoprofen, one of the nonsteroidal anti-inflammatory drugs, prolongs the recovery process of naturally acquired upper respiratory tract infections (URTIs) in the clinical setting." | 9.12 | Influence of loxoprofen use on recovery from naturally acquired upper respiratory tract infections: a randomized controlled trial. ( Ando, M; Aono, M; Goto, M; Kawamura, T; Miyaki, K; Nohara, T; Shimbo, T; Suzuki, I; Takahashi, O; Watanabe, H, 2007) |
| "To investigate whether loxoprofen, one of the nonsteroidal anti-inflammatory drugs, prolongs the recovery process of naturally acquired upper respiratory tract infections (URTIs) in the clinical setting." | 5.12 | Influence of loxoprofen use on recovery from naturally acquired upper respiratory tract infections: a randomized controlled trial. ( Ando, M; Aono, M; Goto, M; Kawamura, T; Miyaki, K; Nohara, T; Shimbo, T; Suzuki, I; Takahashi, O; Watanabe, H, 2007) |
| "A detection kit for influenza virus A and B antigens was used to determine the presence of influenza virus infection." | 2.76 | Antipyretic and analgesic effects of zaltoprofen for the treatment of acute upper respiratory tract infection: verification of a noninferiority hypothesis using loxoprofen sodium. ( Azuma, A; Kudoh, S; Nagatake, T; Nakashima, M, 2011) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Azuma, A | 1 |
| Kudoh, S | 1 |
| Nakashima, M | 1 |
| Nagatake, T | 1 |
| Goto, M | 1 |
| Kawamura, T | 1 |
| Shimbo, T | 1 |
| Takahashi, O | 1 |
| Ando, M | 1 |
| Miyaki, K | 1 |
| Nohara, T | 1 |
| Watanabe, H | 1 |
| Suzuki, I | 1 |
| Aono, M | 1 |
2 trials available for loxoprofen and Respiratory Tract Infections
| Article | Year |
|---|---|
Antipyretic and analgesic effects of zaltoprofen for the treatment of acute upper respiratory tract infection: verification of a noninferiority hypothesis using loxoprofen sodium.
Topics: Administration, Oral; Adult; Anti-Inflammatory Agents, Non-Steroidal; Antipyretics; Benzopyrans; Bod | 2011 |
Influence of loxoprofen use on recovery from naturally acquired upper respiratory tract infections: a randomized controlled trial.
Topics: Adolescent; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Double-Blind Method; Female; Human | 2007 |